Home NDC 52747-475 Norel AD
Product NDC 52747-475
11-digit product format 527470475
Labeler code 52747
Product ID 52747-475_41619e00-e834-2cf6-e063-6394a90a259d
Type HUMAN OTC DRUG
Nonproprietary name acetaminophen, chlorpheniramine maleate, and phenylephrine HCl
Dosage form TABLET, MULTILAYER
Route ORAL
Labeler U.S. PHARMACEUTICAL CORPORATION
Application M012
Marketing category OTC MONOGRAPH DRUG
Marketing start 2012-04-27
Substance ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE
Active strength 325; 4; 10 mg/1; mg/1; mg/1
Pharmacologic classes Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Norel AD
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ACETAMINOPHEN 325 mg/1 CHLORPHENIRAMINE MALEATE 4 mg/1 PHENYLEPHRINE HYDROCHLORIDE 10 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 3 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 362O9ITL9D Internal UNII lookup V1Q0O9OJ9Z Internal UNII lookup 04JA59TNSJ Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1193293 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 52747-475-70 Norel AD 20 in 1 BOTTLE TABLET, MULTILAYER 20 14
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded ACETAMINOPHEN ACTIVE INGREDIENT 362O9ITL9D NOREL AD (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL) TABLET, MULTILAYER [US PHARMACEUTICAL CORPORATION] 5 CHLORPHENIRAMINE MALEATE ACTIVE INGREDIENT V1Q0O9OJ9Z NOREL AD (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL) TABLET, MULTILAYER [US PHARMACEUTICAL CORPORATION] 5 PHENYLEPHRINE HYDROCHLORIDE ACTIVE INGREDIENT 04JA59TNSJ NOREL AD (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL) TABLET, MULTILAYER [US PHARMACEUTICAL CORPORATION] 5 ACETAMINOPHEN ACTIVE MOIETY 362O9ITL9D NOREL AD (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL) TABLET, MULTILAYER [US PHARMACEUTICAL CORPORATION] 5 CHLORPHENIRAMINE ACTIVE MOIETY 3U6IO1965U NOREL AD (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL) TABLET, MULTILAYER [US PHARMACEUTICAL CORPORATION] 5 PHENYLEPHRINE ACTIVE MOIETY 1WS297W6MV NOREL AD (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL) TABLET, MULTILAYER [US PHARMACEUTICAL CORPORATION] 5 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U NOREL AD (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL) TABLET, MULTILAYER [US PHARMACEUTICAL CORPORATION] 5 COLLOIDAL SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 NOREL AD (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL) TABLET, MULTILAYER [US PHARMACEUTICAL CORPORATION] 5 CROSPOVIDONE INACTIVE INGREDIENT 68401960MK NOREL AD (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL) TABLET, MULTILAYER [US PHARMACEUTICAL CORPORATION] 5 D&C YELLOW NO. 10 INACTIVE INGREDIENT 35SW5USQ3G NOREL AD (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL) TABLET, MULTILAYER [US PHARMACEUTICAL CORPORATION] 5 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 NOREL AD (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL) TABLET, MULTILAYER [US PHARMACEUTICAL CORPORATION] 5 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 NOREL AD (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL) TABLET, MULTILAYER [US PHARMACEUTICAL CORPORATION] 5 POVIDONE K30 INACTIVE INGREDIENT U725QWY32X NOREL AD (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL) TABLET, MULTILAYER [US PHARMACEUTICAL CORPORATION] 5 STARCH, PREGELATINIZED CORN INACTIVE INGREDIENT O8232NY3SJ NOREL AD (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL) TABLET, MULTILAYER [US PHARMACEUTICAL CORPORATION] 5 STEARIC ACID INACTIVE INGREDIENT 4ELV7Z65AP NOREL AD (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL) TABLET, MULTILAYER [US PHARMACEUTICAL CORPORATION] 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 52747-475 NOREL AD (ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HCL) TABLET, MULTILAYER [U.S. PHARMACEUTICAL CORPORATION] 13 Current NDC, Legacy NDC, 1 package rows 20241017_53d9ed3c-212d-4b12-ac35-8bd49382b49d.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 74 of 180 · 3,583 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 52747-475-70 52747047570 20 TABLET, MULTILAYER in 1 BOTTLE (52747-475-70) 2012-04-27 0000-00-00 No No Current